Home » Newsletters » BioWorld Science

BioWorld Science

May 11, 2021

View Archived Issues

Enobosarm confers clinical benefit in patients with AR+/ER+ metastatic breast cancer

ChemoCentryx describes new PD-1/PD-L1 interaction inhibitors

Stanford University presents new anticancer peptides

New antibacterials discovered at Wockhardt

TroBio Therapeutics identifies new tropomyosin alpha-3 chain inhibitors

AAV9 encoding NPC intracellular cholesterol transporter 1 synthesized at StrideBio

TRPV1 antagonist SAF-312 reduces pain after photorefractive keratectomy

Natural language processing identifies impact of diazoxide choline on Prader-Willi syndrome

Anti-CD3 DARPin T-cell engager is active only in the tumor microenvironment

IMV to initiate phase Ib study of maveropepimut-S in breast cancer

Checkmate and Regeneron enter agreement to evaluate vidutolimod plus cemiplimab

Diffusion reports final data from phase Ib study of TSC in hospitalized COVID-19 patients

Key interim analysis findings from phase Ia/Ib monotherapy study of CUE-101 in HNSCC

G1 Therapeutics initiates phase II PRESERVE 4 study of trilaciclib in NSCLC

First patient dosed in phase I/II study of CBX-12 in advanced or metastatic refractory solid tumors

GBR-830 shows improvement at 16 weeks in patients with moderate to severe atopic dermatitis

Novel progression risk tissue markers in premalignant cervical lesions

Ascendis reports 58-week data from phase II OLE study of TransCon PTH in hypoparathyroidism

FDA authorizes Pfizer and BioNTech's COVID-19 vaccine for adolescents aged 12-15 years

Gavo-cel shows promising phase I/II results in patients with mesothelin-overexpressing solid tumors

Hamlet Pharma reports dose-escalation data on Alpha-1H in bladder cancer

Phase I trial of Ampion in long COVID receives IRB approval

Enrollment opens in phase II study of BA-3011 for metastatic NSCLC

New phase I trial evaluates PBCAR-19B in CD19-expressing malignancies

SARS-CoV-2 vaccines make progress in the young, the old, the in-between

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...
Research grants support early clinical trials of ALS treatments
BioWorld Science
The ALS Association has announced the recipients of its 2025 Hoffman ALS Clinical Trial Awards. These research grants, worth up to $1 million each, support...